Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on
暂无分享,去创建一个
Santiago Pérez-Hoyos | Ildefonso Hernández-Aguado | Roberto Muga | Inma Ferreros | Julia del Amo | Jorge del Romero | Patricia Garcia de Olalla
[1] J. Margolick,et al. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis , 2001, AIDS.
[2] Kholoud Porter,et al. Determinants of survival following HIV-1 seroconversion after the introduction of HAART , 2003, The Lancet.
[3] Progression to AIDS slowed even more after the first two years with highly active antiretroviral therapy , 2003, Scandinavian journal of public health.
[4] Santiago Pérez-Hoyos,et al. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category , 2003, AIDS.
[5] A Muñoz,et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. , 1998, JAMA.